Knoop et al. utilized human mesenchymal stem cells as delivery vectors for the sodium iodide symporter in the treatment of hepatocellular cancer, resulting in a 55% reduction in cancer cell survival [20]. Here, SLC5A5 is linked to hepatocellular carcinoma.